Does Oral Beta-Blocker Therapy Improve Long-Term Survival in ST-Segment Elevation Myocardial Infarction With Preserved Systolic Function? A Meta-Analysis
Conclusion:
This meta-analysis demonstrates that oral beta-blocker therapy is associated with decreased all-cause mortality in patients with STEMI who are treated with primary PCI and who have preserved LVEF. This supports the current American College of Cardiology Foundation/American Heart Association 2013 Guideline for the Management of STEMI.
Source: Journal of Cardiovascular Pharmacology and Therapeutics - Category: Cardiology Authors: Misumida, N., Harjai, K., Kernis, S., Kanei, Y. Tags: Clinical Studies Source Type: research
More News: Angioplasty | Beta-Blockers | Cardiology | Cardiovascular | Coronary Angioplasty | Drugs & Pharmacology | Heart | Heart Attack | Percutaneous Coronary Intervention | Study